Applying our C3Tag DCIS cancer cell gene signature on human DCIS datasets, we found that our C3Tag signature was significantly higher in basal-like DCIS versus non-basal-like DCIS, especially the ER+ LumA-like DCIS. The gene discussed is ESR1; the disease is ductal breast carcinoma in situ.